1,142
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation

, , , , , , , & show all
Pages 201-214 | Received 28 Aug 2023, Accepted 08 Jan 2024, Published online: 02 Feb 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.